GlassScriptPhysician profile
Jorge A Hernandez
NPI 1104069079
$1,428.56
in general payments reported to CMS, 2019-2025
18 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $37.63 · 2021: $157 · 2022: $128 · 2023: $397 · 2024: $164 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $633.14 | 2022-2025 | Citrefix, Prostep, Salvation |
| Depuy Synthes Sales INC. | $176.31 | 2023-2024 | Hammerlock |
| Integra Lifesciences Corporation | $76.27 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Djo, LLC | $71.80 | 2019-2020 | |
| Convatec INC. | $66.77 | 2025 | |
| Smith+Nephew, INC. | $54.13 | 2024 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Paratek Pharmaceuticals, INC. | $51.06 | 2021-2023 | Nuzyra |
| Grt US Holding, INC. | $49.90 | 2021 | |
| Zimmer Biomet Holdings, INC. | $39.84 | 2019-2021 | |
| Bioventus LLC | $36.03 | 2019-2021 | |
| Nabriva Therapeutics, Plc | $33.08 | 2020-2021 | |
| Organogenesis INC. | $30.84 | 2021 | |
| Paragon 28, INC. | $29.29 | 2019 | |
| Acera Surgical, INC. | $19.11 | 2022 | |
| Stimwave Technologies Incorporated | $18.33 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $17.79 | 2019 | |
| Acell, INC. | $12.80 | 2019 | |
| Iroko Pharmaceuticals, LLC | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.